Pulse Biosciences (PLSE)
Develops nPulse systems for soft-tissue and atrial-fibrillation ablation.
$52.70
At close+0.61 (+1.17%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions98 holders · as of Mar 31, 2026 | 10.89% | 7.77M shares | |
| Insiders8 holders · as of Sep 2, 2026 | 71.10% | 50.71M shares | |
| Otherremainder | 18.01% | 12.84M shares |
71.32M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
98 holders · 7.77M shares · 33 new positions · 59 increased · 24 reduced · 19 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.34M | 1.88% | −17.2K | May 13, 2026 |
| Bank of America Corp /DE/ | 866.1K | 1.21% | +65.9K | May 18, 2026 |
| Vanguard Capital Management LLC | 815.9K | 1.14% | +815.9Knew | May 15, 2026 |
| Portolan Capital Management, LLC | 733.4K | 1.03% | +339.9K | May 15, 2026 |
| Geode Capital Management, LLC | 491.9K | 0.69% | +27.3K | May 15, 2026 |
| Massachusetts Financial Services Co /MA/ | 462.9K | 0.65% | +462.9Knew | May 14, 2026 |
| State Street Corp | 456.9K | 0.64% | +9.9K | May 15, 2026 |
| Balyasny Asset Management L.P. | 265.2K | 0.37% | +265.2Knew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Robert W. Dugganincl. Blazon Corporation, Genius 24C Inc | 71.90% | 49.71M | 13D | May 13, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 1, 2026 | Liane Rae Teplitskyofficer: Chief Operating Officer | Purchase | 1,001 | $49.95 | 4,095 |
| Aug 31, 2026 | Liane Rae Teplitskyofficer: Chief Operating Officer | Purchase | 1,024 | $48.80 | 3,094 |
| Aug 28, 2026 | Liane Rae Teplitskyofficer: Chief Operating Officer | Purchase | 1,034 | $48.35 | 2,070 |
| Aug 26, 2026 | Liane Rae Teplitskyofficer: Chief Operating Officer | Purchase | 1,036 | $48.24 | 1,036 |
| May 11, 2026 | Robert W. Duggandirector, 10 percent owner: | Purchase | 660,233 | $19.69 | 48,370,047 |
| May 11, 2026 | Paul A. Laviolettedirector, officer: Chief Executive Officer | Purchase | 15,000 | $19.69 | 15,846 |
| Feb 18, 2026 | Kevin Patrick Danahyofficer: Chief Commercial Officer | Sale | 5,000 | $23.64 | 43,298 |
| Feb 12, 2026 | Kevin Patrick Danahyofficer: Chief Commercial Officer | Sale | 20,000 | $23.37 | 43,298 |
| Feb 17, 2026 | Kevin Patrick Danahyofficer: Chief Commercial Officer | Sale | 20,000 | $23.63 | 43,298 |
| Feb 13, 2026 | Kevin Patrick Danahyofficer: Chief Commercial Officer | Sale | 20,000 | $23.53 | 43,298 |
CongressHouse and Senate disclosures
Not reported.